<DOC>
	<DOCNO>NCT00548132</DOCNO>
	<brief_summary>We propose perform prospective randomize control trial study effect use commercially-available chlorhexidine-impregnated sponge ( Biopatch ) part central venous catheter care catheter-related bloodstream infection among patient two Barnes-Jewish Hospital ICUs .</brief_summary>
	<brief_title>Reducing Catheter-Related Bloodstream Infections ICU With Chlorhexidine-Impregnated Sponge ( BIOPATCH )</brief_title>
	<detailed_description>At time inception study , publish randomize controlled trial efficacy Biopatch reduce bloodstream infection . Preliminary data show Biopatch decrease colonization catheter exit site thereby decrease bloodstream infection time theoretical .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>patient admit ICU central venous catheter ( i.e . triple lumen catheter , quadruple lumen catheter , percutaneously inserted central catheter , arterial catheter , intraaortic balloon pump , SwanGanz catheter ) . patient enrol trial within 7 day catheter place patient allergic chlorhexidine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>